23andMe
also invests · investor profileMountain View, US · Delaware corporation · 557 employees on LinkedIn · 19 known investors
23andMe operates a research platform that collects genetic data from millions of users to advance genomic research and health discovery. The company enables individuals to learn about their genetic traits while contributing to medical research studies that benefit public health.
Founders & leadership
AW
Anne Wojcickiin𝕏Co-founder & CEO
LA
Linda AveyCo-founder
PC
Paul CheungCo-founder
AP
Andrew PageExecutive
KH
Kathy HibbsExecutive
Board
ED
Esther DysonBoard director
PC
Investors · 19
Allied Venture PartnersCalgary · $100K – $350K
Civilization Ventures Management, LlcTiburon · $1M – $10M
EQUIAMSan Francisco · $1M – $10M
G SquaredChicago
Houston Angel NetworkHouston
InvestXVancouver
Jazzya InvestmentsAlcobendasvia Martin Varsavsky · inferred
Lauder PartnersLos Altosvia Gary Lauder · inferred
New Enterprise Associates (NEA)Menlo Park · $200K – $40M
Sapphire VenturesMenlo Park · $5M – $20M
Second Alpha PartnersNew York
SteelSky VenturesAtlanta · $100K – $5M
XfundPalo Alto · $50K – $500Kvia Patrick Chung · board
Altimeter CapitalreportedMenlo Park · $1M – $25M
Casdin CapitalreportedNew York
Fidelity InvestmentsreportedBoston
Future Planet CapitalreportedLondon
Sequoia Capitalreported · 3 sourcesMenlo Park · $4.4M – $214Mvia Roelof Botha · board
WuXi Healthcare VenturesreportedGrand Cayman
Reported raises · per SEC filings
Form D private placements$711.6M disclosed across 4 rounds · 2015–2020
▶$82.5MraisedDec 2020 · 23 investors · Other TechnologyRule 506(b)
▶$82.5MraisedDec 2020 · 23 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Anne WojcickiExecutive Officer, Director
- Kathy HibbsExecutive Officer
- Steven SchochExecutive Officer
- Roelof BothaDirector
- Patrick ChungDirector
- Richard SchellerDirector
- Neal MohanDirector
- Offering amount
- $85M
- Amount sold
- $82.5M
- First sale
- Dec 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$300MraisedAug 2018 · 1 investors · Other TechnologyRule 506(b)
▶$300MraisedAug 2018 · 1 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Patrick ChungDirector
- Anne WojcickiExecutive Officer, Director
- Steven SchochExecutive Officer
- Esther DysonDirector
- Roelof BothaDirector
- Neal MohanDirector
- Kathy HibbsExecutive Officer
- Offering amount
- $300M
- Amount sold
- $300M
- First sale
- Jul 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$250MraisedSep 2017 · 31 investors · Other TechnologyRule 506(b)
▶$250MraisedSep 2017 · 31 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Kathy L. HibbsExecutive Officer
- Neal MohanDirector
- Dean SchornoExecutive Officer
- Roelof BothaDirector
- Anne WojcickiExecutive Officer, Director
- Esther DysonDirector
- Patrick S. ChungDirector
- Offering amount
- $250M
- Amount sold
- $250M
- Finders' fees
- $7.5M
- Placement agents
- Allen & Company LLC
- First sale
- Aug 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$79.1MraisedJul 2015 · 15 investors · Other TechnologyRule 506(b)
▶$79.1MraisedJul 2015 · 15 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Anne WojcickiExecutive Officer, Director
- Andrew PageExecutive Officer, Director
- Esther DysonDirector
- Kathy HibbsExecutive Officer
- Patrick ChungDirector
- Offering amount
- $150M
- Amount sold
- $79.1M
- First sale
- Jun 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
4 people who came through 23andMe went on to found or lead other companies.
Competitors · 1
by search overlapCompanies competing with 23andMe for the same Google search keywords, organic and paid, via search-intersection analysis.
Acquisitions · 1
Early investors' stakes continue via these dealsLemonaid
Lemonaid Health is a telehealth company that lets patients access medical care and treatment online from home, including services like contraceptive pill prescriptions and UTI treatment. It serves patients primarily in the United States, with a later launch in the UK.
In the news
23andMe confirms $250M round led by Sequoiatechcrunch.com · Sep 2017
Equity podcast: Roku is going public, 23andMe raises $200M and Juicero is deadtechcrunch.com · Sep 2017
23andMe hits $1.5B pre-money valuation in latest huge funding roundtechcrunch.com · Sep 2017
23andMe is raising about $200M, led by Sequoiatechcrunch.com · Sep 2017
23andMe Wins a Second Life, Raises $115Mforbes.com · Oct 2015Frequently asked questions
- What does 23andMe do?
- 23andMe operates a research platform that collects genetic data from millions of users to advance genomic research and health discovery. The company enables individuals to learn about their genetic traits while contributing to medical research studies that benefit public health.
- Who founded 23andMe?
- 23andMe was founded by Anne Wojcicki, Linda Avey, Paul Cheung.
- Who are 23andMe's investors?
- 23andMe's investors include Allied Venture Partners, Civilization Ventures Management, Llc, EQUIAM, G Squared, Houston Angel Network, InvestX, Jazzya Investments, Lauder Partners and 11 more.
- How much funding has 23andMe raised?
- 23andMe has disclosed $711.6M raised across 4 rounds.
- Where is 23andMe headquartered?
- 23andMe is headquartered in Mountain View, US.